Home › Funds › TCG Crossover Management, LLC › RLAY
TCG Crossover Management, LLC position in RLAY
RELAY THERAPEUTICS INC · Health Care
TCG Crossover Management, LLC reported holding 4,273,356 shares of RLAY (RELAY THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$80.0M, representing 1.92% of its reported portfolio and ranking #17 among its reported holdings. TCG Crossover Management, LLC has disclosed RLAY holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How TCG Crossover Management, LLC's RLAY position evolved
TCG Crossover Management, LLC first disclosed a stake in RLAY in Q3 2025 at 1,810,351 shares (US$9.5M). The position peaked in Q2 2026 at 4,273,356 shares, worth US$80.0M. Across 4 filings, TCG Crossover Management, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 4,273,356 shares valued at US$80.0M. Notable position changes include a 78% increase in Q4 2025 (shares rose 18% over the following quarter), a 33% increase in Q1 2026 (shares rose 88% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 1.81M | $9.45M | New |
| Q4 2025 | 3.22M | $27.24M | Add |
| Q1 2026 | 4.27M | $42.52M | Add |
| Q2 2026 | 4.27M | $79.95M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RLAY and 13F data
RLAY (RELAY THERAPEUTICS INC) is a Health Care company. 64 other funds we track also report a position in RLAY — the largest reported positions include SB INVESTMENT ADVISERS (UK) LTD (US$522.1M), Casdin Capital (US$300.0M), PERCEPTIVE ADVISORS LLC (US$263.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RLAY
- SB INVESTMENT ADVISERS (UK) LTD 27.90M sh · $522.10M · Q2 2026
- Casdin Capital 16.04M sh · $300.02M · Q2 2026
- PERCEPTIVE ADVISORS LLC 14.11M sh · $263.93M · Q2 2026
- Commodore Capital LP 12.00M sh · $224.52M · Q2 2026
- Nextech Invest Ltd. 6.78M sh · $126.79M · Q2 2026
- Bellevue Group AG 6.19M sh · $115.74M · Q2 2026
- Siren, L.L.C. 3.65M sh · $68.29M · Q2 2026
- Kynam Capital Management, LP 3.30M sh · $61.74M · Q2 2026
- Spruce Street Capital LP 2.98M sh · $55.83M · Q2 2026
- BAKER BROS. ADVISORS LP 2.83M sh · $52.89M · Q2 2026
- MPM BioImpact LLC 2.42M sh · $45.20M · Q2 2026
- Elmind Capital, LP 1.47M sh · $27.42M · Q2 2026
More on TCG Crossover Management, LLC
FAQ
How long has TCG Crossover Management, LLC held RLAY?
TCG Crossover Management, LLC has disclosed RLAY holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is TCG Crossover Management, LLC's current position in RLAY?
As of Q2 2026, TCG Crossover Management, LLC holds 4.27M shares of RLAY (RELAY THERAPEUTICS INC), valued at $79.95M, representing 1.92% of its reported portfolio and ranking #17.
Has TCG Crossover Management, LLC been buying or selling RLAY?
In the latest 13F filing (Q2 2026), TCG Crossover Management, LLC held unchanged its position in RLAY. The position peaked in Q2 2026 at 4.27M shares.
Which other funds hold RLAY?
Other major institutional holders of RLAY include SB INVESTMENT ADVISERS (UK) LTD, Casdin Capital, PERCEPTIVE ADVISORS LLC, among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.